10669383

Source:http://linkedlifedata.com/resource/pubmed/id/10669383

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0014661, umls-concept:C0024198, umls-concept:C0086231, umls-concept:C0180745, umls-concept:C0220908, umls-concept:C0439611, umls-concept:C0600324
pubmed:issue	2
pubmed:dateCreated	2000-4-13
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/10669383-10068589
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0413675
pubmed:citationSubset	AIM
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	0022-1899
pubmed:author	pubmed-author:AcetiAA, pubmed-author:PirasM AMA
pubmed:issnType	Print
pubmed:volume	181
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	802-3
pubmed:dateRevised	2004-11-17
pubmed:meshHeading	pubmed-meshheading:10669383-Blotting, Western, pubmed-meshheading:10669383-Cost-Benefit Analysis, pubmed-meshheading:10669383-Humans, pubmed-meshheading:10669383-Immunoenzyme Techniques, pubmed-meshheading:10669383-Lyme Disease, pubmed-meshheading:10669383-Mass Screening, pubmed-meshheading:10669383-Sensitivity and Specificity, pubmed-meshheading:10669383-Serologic Tests
pubmed:year	2000
pubmed:articleTitle	Preliminary falsification of EIA screening is cost-effective in the two-step serodiagnosis of lyme disease.
pubmed:publicationType	Letter, Comment